Genetic Technologies Limited Sponsored ADR Stock

$0.77

0.65%

Nasdaq, Nov 22, 03:30 pm CET

ISIN

US37185R2085

Symbol

GENE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Genetic Technologies Limited Sponsored ADR Stock price

$0.77

-9.44 92.50% 5Y

Nasdaq, Closing price Mon, Nov 25 2024

+0.00 0.00%

ISIN

US37185R2085

Symbol

GENE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$6.23m
Enterprise Value	$6.13m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	1.22
P/S ratio (TTM) P/S ratio	1.24
P/B ratio (TTM) P/B ratio	2.89
Revenue growth (TTM) Revenue growth	-14.07%
Revenue (TTM) Revenue	$5.02m
EBIT (operating result TTM) EBIT	$-7.05m
Free Cash Flow (TTM) Free Cash Flow	$-6.30m
EPS (TTM) EPS	$-1.83
Short interest	0.56%

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Get Started for Free Today

Genetic Technologies Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast Genetic Technologies Limited Sponsored ADR:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast Genetic Technologies Limited Sponsored ADR:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Genetic Technologies Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Jun '24		+/- %
Revenue	5.02 5.02	14% 14% 100%
- Direct Costs	7.93 7.93	3% 3% 158%
Gross Profit	-2.91 -2.91	56% 56% -58%
- Selling and Administrative Expenses	3.30 3.30	7% 7% 66%
- Research and Development Expense	0.49 0.49	43% 43% 10%
EBITDA	-6.70 -6.70	7% 7% -133%
- Depreciation and Amortization	0.35 0.35	24% 24% 7%
EBIT (Operating Income) EBIT	-7.05 -7.05	5% 5% -140%
Net Profit	-7.87 -7.87	1% 1% -157%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Genetic Technologies Limited Sponsored ADR Stock News

Neutral

Accesswire

●

about 2 months ago

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET).

Neutral

GlobeNewsWire

●

2 months ago

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to invite investors to a webinar on October 2, 2024, at 4:15 p.m. ET.

Neutral

GlobeNewsWire

●

3 months ago

Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has negotiated a partnership agreement with Chicago-based CancerIQ.

More Genetic Technologies Limited Sponsored ADR News

Company Profile

Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Head office	Australia
CEO	Simon Morriss
Employees	58
Founded	1987
Website	www.genetype.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now